Onxeo to Receive $6.6 Million by Granting Additional Exclusive Rights to Belinostat to Acrotech Biopharma LLC

NEXT STORY
Pharmactive Adopts Saffron through ABC’s Adopt-an-Herb Program
PREV STORY
Rafarma Establishes Advisory Board, Appoints First Member and Will Acquire Additional Patents and Intellectual Property
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Athenex Expands its Strategic Partnership with Guangzhou Xiangxue Pharmaceutical Through a Licensing Agreement for its Product Candidates Oral Paclitaxel and Oral Irinotecan, as well as Tirbanibulin Ointment, in China, Hong Kong and Macao

author_avatar
NASDAQ Market News

Ascendis Pharma Announces Two Posters on Rare Disease Pipeline Programs at ENDO 2018

- Baseline demographics of TransCon Growth Hormone phase 3 heiGHt Trial presented - - ...

author_avatar
NASDAQ Market News

Half-year report and dividend declaration

author_avatar
NASDAQ Market News